Sunhawk Vision Biotech

Sunhawk Vision Biotech EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sunhawk Vision Biotech (7759.TWO) as of Oct 18, 2026 is -175.37 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -101.15 M TWD — a change of 73.37% (lower).

EBITDA

-175.37 MTWD

YoY

73.37%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sunhawk Vision Biotech is 2025 -175.37 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sunhawk Vision Biotech was 2024 -101.15 M TWD. It decreases by 73.37% lower compared to the previous year.

The Sunhawk Vision Biotech EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2021
-39.63 M TWD
Jan 1, 2022
-15.55 M TWD
Jan 1, 2023
-113.07 M TWD
Jan 1, 2024
-101.15 M TWD
Jan 1, 2025
-175.37 M TWD
The Sunhawk Vision Biotech EBITDA history
YEAREBITDAYoY
-175.37 MTWD+73.37%
-101.15 MTWD-10.54%
-113.07 MTWD+627.02%
-15.55 MTWD-60.76%
-39.63 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sunhawk Vision Biotech Stock analysis

What does Sunhawk Vision Biotech do? Sunhawk Vision Biotech Inc, based in Kaohsiung, Taiwan, develops ophthalmic treatments. The company focuses on eye drops SHJ002 for myopia prevention in children, DED for dry eyes, and SJP for corneal damage in Sjogren's syndrome patients. With 15 employees, it operates through partnerships with pharmaceutical firms to secure regulatory approvals and technical collaborations globally. Listed on March 10, 2025, the company targets the global eye care market with its innovative drug portfolio. Sunhawk Vision Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunhawk Vision Biotech stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sunhawk Vision Biotech is -175.37 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sunhawk Vision Biotech changed from -101.15 M TWD to -175.37 M TWD, representing a 73.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Sunhawk Vision Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Sunhawk Vision Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Sunhawk Vision Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sunhawk Vision Biotech